Białka nabłonka urzęsionego: CFAP36 i sentan w plwocinie indukowanej jako możliwe nowe markery uszkodzenia nabłonka w obturacyjnych chorobach płuc – badanie wstępne
Magdalena Paplińska-Goryca 1 , Paulina Misiukiewicz-Stępień 2 , Katarzyna Górska 1 , Rafał Krenke 1Abstrakt
Background: Asthma and chronic obstructive pulmonary disease (COPD) are the most common chronic respiratory diseases characterized by inflammation in the lower airways and epithelium remodeling. Dysfunction of cilium is related to severe asthma and COPD, the role of cilium proteins in obstructive lung diseases is not known. The aim of the study was to evaluate the concentration of cilia associated proteins: sentan and CFAP36 in induced sputum (IS) of asthma and COPD patients. Materials/Methods: The study involved 15 patients with asthma, 12 patients with COPD and 17 control subjects (9 non-smoking, 8 smoking) who underwent lung function tests and sputum induction. Sentan, CFAP36, IL-6, IL-8, concentrations were measured in induced sputum supernatants by ELISA. Results: The level of CFAP36 in induced sputum was elevated in asthma patients and subjects with atopy. Cilium protein levels in sputum were not related to spirometric tests results. Both CFAP36 and sentan concentrations were positively correlated with age. The level of sentan was associated with airway neutrophilic inflammation and active smoking status. CFAP36 concentration was negatively related to cell viability, whereas sentan level was positively related, but only in COPD patients. Conclusions: The results of our study revealed CFAP36 and sentan as possible new markers of epithelial damage of different origin in obstructive lung diseases.
Przypisy
- 1. Badano J.L., Mitsuma N., Beales P.L., Katsanis N.: The ciliopathies:An emerging class of human genetic disorders. Annu. Rev.Genomics Hum. Genet., 2006; 7: 125–148
Google Scholar - 2. Fahy J.V., Dickey B.F.: Airway mucus function and dysfunction.N. Engl. J. Med., 2010; 363: 2233–2247
Google Scholar - 3. Global Strategy for Asthma Management and Prevention.www.ginasthma.org
Google Scholar - 4. Global Strategy for the Diagnosis, Management and Preventionof COPD, Global Initiative for Chronic Obstructive Lung Disease(GOLD). http://goldcopd.org
Google Scholar - 5. Halbeisen F.S., Jose A., de Jong C., Nyilas S., Latzin P., KuehniC.E., Goutaki M.: Spirometric indices in primary ciliary dyskinesia:Systematic review and meta-analysis. ERJ Open Res., 2019;5: 00231–2018
Google Scholar - 6. Hessel J., Heldrich J., Fuller J., Staudt M.R., Radisch S., HollmannC., Harvey B.G., Kaner R.J., Salit J., Yee-Levin J., Sridhar S., Pillai S.,Hilton H., Wolff G., Bitter H., et al.: Intraflagellar transport geneexpression associated with short cilia in smoking and COPD. PLoSOne, 2014; 9: e85453
Google Scholar - 7. Innes A.L., Carrington S.D., Thornton D.J., Kirkham S., RousseauK., Dougherty R.H., Raymond W.W., Caughey G.H., Muller S.J., FahyJ.V.: Ex vivo sputum analysis reveals impairment of protease-dependentmucus degradation by plasma proteins in acute asthma.Am. J. Respir. Crit. Care Med., 2009; 180: 203–210
Google Scholar - 8. Jorissen M.: Correlations among mucociliary transport, ciliaryfunction, and ciliary structure. Am. J. Rhinol., 1998; 12: 53–58
Google Scholar - 9. Khan N.A., Willemarck N., Talebi A., Marchand A., Binda M.M.,Dehairs J., Rueda-Rincon N., Daniels V.W., Bagadi M., Thimiri GovindaRaj D.B., Vanderhoydonc F., Munck S., Chaltin P., SwinnenJ.V.: Identification of drugs that restore primary cilium expressionin cancer cells. Oncotarget, 2016; 7: 9975–9992
Google Scholar - 10. Liu T., Wang F.P., Wang G., Mao H.: Role of neutrophil extracellulartraps in asthma and chronic obstructive pulmonary disease.Chin. Med. J., 2017; 130: 730–736
Google Scholar - 11. Paplińska-Goryca M., Goryca K., Misiukiewicz P., Nejman-GryzP., Górska K., Krenke R.: Genetic characterization of macrophagesfrom induced sputum of patients with asthma and chronic obstructivepulmonary disease. Pol. Arch. Intern. Med., 2018; 128: 559–562
Google Scholar - 12. Paplińska-Goryca M., Nejman-Gryz P., Górska K., Białek-GoskK., Hermanowicz-Salamon J., Krenke R.: Expression of inflammatorymediators in induced sputum: Comparative study in asthmaand COPD. Adv. Exp. Med. Biol., 2018, 1040: 101–113
Google Scholar - 13. Patton J.S., Byron P.R.: Inhaling medicines: Delivering drugs tothe body through the lungs. Nat. Rev. Drug Discov., 2007; 6: 67–74
Google Scholar - 14. Position paper: Allergen standardization and skin tests. TheEuropean Academy of Allergology and Clinical Immunology.Allergy, 1993; 48: 48–82
Google Scholar - 15. Qiao D., Ameli A., Prokopenko D., Chen H., Kho A.T., ParkerM.M., Morrow J., Hobbs B.D., Liu Y., Beaty T.H., Crapo J.D., BarnesK.C., Nickerson D.A., Bamshad M., Hersh C.P., et al.: Whole exomesequencing analysis in severe chronic obstructive pulmonary disease.Hum. Mol. Genet., 2018; 27: 3801–3812
Google Scholar - 16. Stannard W., O’Callaghan C.: Ciliary function and the role ofcilia in clearance. J. Aerosol Med., 2006; 19: 110–115
Google Scholar - 17. Thomas B., Rutman A., Hirst R.A., Haldar P., Wardlaw A.J.,Bankart J., Brightling C.E., O’Callaghan C.: Ciliary dysfunctionand ultrastructural abnormalities are features of severe asthma.J. Allergy Clin. Immunol., 2010; 126: 722–729.e2
Google Scholar - 18. Yaghi A., Dolovich M.B.: Airway epithelial cell cilia and obstructivelung disease. Cells, 2016; 5: 40
Google Scholar - 19. Yaghi A., Zaman A., Cox G., Dolovich M.B.: Ciliary beating isdepressed in nasal cilia from chronic obstructive pulmonary diseasesubjects. Respir. Med., 2012; 106: 1139–1147
Google Scholar